Temporary disabilities by rheumatic diseases cost of € 305 million a year in the community of Madrid.
one out of four people 20 years of age or older suffering from rheumatic in Madrid illness
-the eleven Foundation welcomes today, Thursday, October 20, a briefing on ankylosing spondylitis by EDEPA, organized in collaboration with Abbott
-An informed patient and active is key to preventing and treating manifestations extra articular, affecting more than 40% of patients with ankylosing
Madrid, 2011-October according to the impact study of rheumatic diseases in Spain, carried out by the platform health and work, temporary disabilities by rheumatic diseases pose a cost of € 305 million a year in the community of Madrid, derived from the almost 150,000 processes of disability it causes. Within these pathologies is ankylosing spondylitis which is, along with rheumatoid arthritis, one of the most disabling diseases.
This degenerative disease, vertebrae tend to be welded together, resulting in limitation of mobility on the patient. For Dr. Juan Carlos López Robledillo, President of the society of Rheumatology of the community of Madrid (SORCOM), in ankylosing spondylitis, diagnosing and treating early is key to avoid inflammation, which eventually can lead to joint destruction, which leads to the inability of the patient. In this sense, the emergence of biological treatments, such as the Anti-TNF, allows that, if you start the treatment in the initial stages of the disease, the patient responds extremely well ”.
With this objective, those suffering from spondylitis and arthritis Parleños partners (EDEPA), in collaboration with Abbott, organizes today, Thursday, October 20, 18: 00, a briefing on this disease. The importance of the patient informed about its pathology which takes an active role to deal with the challenges faces it with the disease on the day. For Miguel Ãngel GarcÃa, President of EDEPA, in this type of diseases, a patient active is key to ensure adherence to treatment, resulting in an improvement in their quality of life ”.
The talk, to be held in the eleven founding (Sebastián Herrera: 15) in Madrid, will begin at 18: 00. The Dres. Juan Carlos López Robledillo, and Eva Gloria Tomero Muriel, medical assistant of the service for University Hospital Rheumatology of the Princess and a member of SORCOM, inform patients about ankylosing spondylitis and be handled all their doubts related to pathology. Likewise, Miguel Ãngel GarcÃaPresident of EDEPA, will affect on the relevance of the role to be taken by the patient.
A greater understanding of the pathology contributes to the prevention and treatment of extra demonstrations joints that it may occur. In this regard, Dr. López Robledillo adds that acts such as the one organized by EDEPA are very beneficial for the patient, providing information about the pathology and the prevention of the extraarticular manifestations at the same time allowing them to solve all your questions directly to a specialist ”.
Extra demonstrations joints are those signs and symptoms that originate in different locomotor tissues and organs, but relate to ankylosing spondylitis, such as Uveitis (inflammation of the uveal – vascular layer of the eye-) or inflammatory bowel disease. According to data from the be 4 of every 10 patients of ankylosing spondylitis have in turn demonstrations extra joints.
About EDEPA
E.D.E.P.A is an apolitical and non-profit, association that has as main purpose meet, foster and promote spondylitis and arthritis patients in different social and labour activities and family. It leads to biological, clinical and epidemiological studies and related diseases, and maintains relations and contacts with centres and national and foreign institutions as regards médicos-tecnológicos advances in the treatment of these diseases.
